| 1 |
Veldhuizen J, Mann HF, Karamanova N, Van Horn WD, Migrino RQ, Brafman D, Nikkhah M. Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues. Sci Adv 2022;8:eabq6720. [PMID: 36525500 DOI: 10.1126/sciadv.abq6720] [Reference Citation Analysis]
|
| 2 |
Peters MC, Maas RGC, van Adrichem I, Doevendans PAM, Mercola M, Šarić T, Buikema JW, van Mil A, Chamuleau SAJ, Sluijter JPG, Hnatiuk AP, Neef K. Metabolic Maturation Increases Susceptibility to Hypoxia-induced Damage in Human iPSC-derived Cardiomyocytes. Stem Cells Transl Med 2022:szac061. [PMID: 36018047 DOI: 10.1093/stcltm/szac061] [Reference Citation Analysis]
|
| 3 |
Häkli M, Jäntti S, Joki T, Sukki L, Tornberg K, Aalto-Setälä K, Kallio P, Pekkanen-Mattila M, Narkilahti S. Human Neurons Form Axon-Mediated Functional Connections with Human Cardiomyocytes in Compartmentalized Microfluidic Chip. Int J Mol Sci 2022;23:3148. [PMID: 35328569 DOI: 10.3390/ijms23063148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 4 |
Boheler KR, Meli AC, Yang HT. Special issue on recent progress with hPSC-derived cardiovascular cells for organoids, engineered myocardium, drug discovery, disease models, and therapy. Pflugers Arch 2021;473:983-8. [PMID: 34131786 DOI: 10.1007/s00424-021-02594-3] [Reference Citation Analysis]
|
| 5 |
Su L, Zhang G, Zhong H, Luo L, Li Y, Chi C, Jiang L, Huang P, Liu G, Zhu P, Kang K. WITHDRAWN: Knocking out c-Jun promotes cardiomyocyte differentiation from embryonic stem cells. Int J Cardiol 2021:S0167-5273(21)00976-1. [PMID: 34139231 DOI: 10.1016/j.ijcard.2021.06.017] [Reference Citation Analysis]
|
| 6 |
Luo XL, Zhang P, Liu X, Huang S, Rao SL, Ding Q, Yang HT. Myosin light chain 2 marks differentiating ventricular cardiomyocytes derived from human embryonic stem cells. Pflugers Arch 2021;473:991-1007. [PMID: 34031754 DOI: 10.1007/s00424-021-02578-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Andrysiak K, Stępniewski J, Dulak J. Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research. Pflugers Arch 2021;473:1061-85. [PMID: 33629131 DOI: 10.1007/s00424-021-02536-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 8 |
Bi W, Wang J, Jiang Y, Li Q, Wang S, Liu M, Liu Q, Li F, Paul C, Wang Y, Yang HT. Neurotrophin-3 contributes to benefits of human embryonic stem cell-derived cardiovascular progenitor cells against reperfused myocardial infarction. Stem Cells Transl Med 2021;10:756-72. [PMID: 33529481 DOI: 10.1002/sctm.20-0456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Li Q, Wang J, Wu Q, Cao N, Yang HT. Perspective on human pluripotent stem cell-derived cardiomyocytes in heart disease modeling and repair. Stem Cells Transl Med 2020;9:1121-8. [PMID: 32725800 DOI: 10.1002/sctm.19-0340] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
